Q: What is Prolia used for?

Prolia is used to treat: Postmenopausal osteoporosis Osteoporosis in men Glucocorticoid-induced osteoporosis Others

Q: How does Prolia work?

Targeting Bone Breakdown The body constantly undergoes a process of bone remodeling, where old bone is broken down and replaced by new bone. In conditions like osteoporosis, bone is broken down faster than it can be replaced, leading to thin and fragile bones. Prolia works by targeting a specific protein in the body called RANK ligand (RANKL). This protein is essential for the formation, function, and survival of osteoclasts, which are the cells responsible for breaking down bone. When Prolia binds to RANKL, it prevents these cells from maturing and functioning. Increasing Bone Strength By slowing down the activity of bone-destroying cells, Prolia helps to: Increase bone mass: More bone tissue is preserved over time. Improve bone density: Bones become thicker and less porous. Reduce fracture risk: Stronger bones are less likely to break, particularly in the spine, hips, and wrists. Because the drug remains active in the body for several months, it provides a sustained reduction in bone loss between doses.

Q: What are the active ingredients in Prolia?

The active ingredient in Prolia is denosumab .

Q: What are the side effects of Prolia?

Common side effects of Prolia may include: back pain extremity pain musculoskeletal pain Always consult with a healthcare professional about potential side effects.

Q: What drug class is Prolia?

Prolia belongs to the RANKL inhibitor drug class.

Q: What is the dosage of Prolia and how do I take it?

How Prolia is Given Prolia is given as an injection under the skin (subcutaneously). It is administered by a healthcare professional in a medical office or clinic. The injection is usually given in the upper arm, the upper thigh, or the stomach area. Dosing Schedule This medication is typically given as a single dose every six months. Your healthcare provider will track your treatment schedule to ensure you receive the medication at the correct intervals. Important Considerations Supplements: To help maintain healthy bone density and blood calcium levels, your doctor will likely instruct you to take calcium and vitamin D supplements while you are receiving this treatment. Missed Doses: If you miss a scheduled injection, contact your healthcare provider immediately to reschedule. After receiving the missed dose, your next injection should be scheduled for six months after that date.

Q: Is Prolia safe during pregnancy and breastfeeding?

Pregnancy Prolia is not recommended for use during pregnancy because it may cause harm to an unborn baby. Research in animals has shown that exposure to the medication during pregnancy can lead to skeletal abnormalities and issues with the development of the immune system in the fetus. If you are capable of becoming pregnant, your healthcare provider may perform a pregnancy test before you begin treatment to ensure you are not pregnant. It is important to use effective birth control while receiving Prolia and for at least 5 months after your last dose. If you become pregnant during this time, notify your healthcare provider immediately. Breastfeeding It is not known whether Prolia passes into human breast milk. Because of the potential for serious side effects in a nursing infant, healthcare providers typically recommend either stopping breastfeeding or stopping the medication. You should discuss your options with your doctor to determine the best course of action based on your medical needs and the health of your baby.

Q: What forms and strengths does Prolia come in?

Dosage Forms Prolia is provided as a liquid solution for subcutaneous injection. It is intended for administration into the fatty tissue under the skin. The medication is supplied in the following form: Prefilled Syringe: A delivery system containing the medication as a clear, colorless-to-pale yellow liquid.

Q: What is the FDA approval status of Prolia?

FDA Approval and Indications Prolia (denosumab) is approved by the U.S. Food and Drug Administration (FDA) for several uses related to bone health. Its primary indications include: Treatment of osteoporosis in postmenopausal women at high risk for fracture. Increasing bone mass in men with osteoporosis at high risk for fracture. Treatment of glucocorticoid-induced osteoporosis in men and women at high risk for fracture. Increasing bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer. Increasing bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Boxed Warning: Severe Hypocalcemia The FDA has added a Boxed Warning to the prescribing information for Prolia. This warning alerts healthcare providers and patients to an increased risk of severe hypocalcemia (critically low blood calcium levels) in patients with advanced chronic kidney disease, particularly those on dialysis. Severe hypocalcemia can lead to serious health issues, including hospitalization or death. The FDA recommends that healthcare providers screen patients for kidney function before prescribing Prolia and monitor calcium levels closely in those with impaired kidney function. Biosimilar Availability In 2024, the FDA approved the first interchangeable biosimilars for Prolia. These medications are biological products that are highly similar to the original drug and have no clinically meaningful differences in terms of safety, purity, and potency.

Question 1

What is Prolia?

Accepted Answer

Prolia is a monoclonal antibody that targets a specific protein in the body called RANK ligand. By binding to this protein, the medication prevents the activation of osteoclasts, which are the cells responsible for breaking down bone tissue.

This action helps to preserve bone density and improve overall bone strength. By slowing the rate at which bone is removed, the therapy supports the maintenance of a healthier bone structure.

Question 2

What is Prolia used for?

Accepted Answer

Prolia is used to treat:

Postmenopausal osteoporosis
Osteoporosis in men
Glucocorticoid-induced osteoporosis
Others

Question 3

How does Prolia work?

Accepted Answer

Targeting Bone Breakdown

The body constantly undergoes a process of bone remodeling, where old bone is broken down and replaced by new bone. In conditions like osteoporosis, bone is broken down faster than it can be replaced, leading to thin and fragile bones.

Prolia works by targeting a specific protein in the body called RANK ligand (RANKL). This protein is essential for the formation, function, and survival of osteoclasts, which are the cells responsible for breaking down bone. When Prolia binds to RANKL, it prevents these cells from maturing and functioning.

Increasing Bone Strength

By slowing down the activity of bone-destroying cells, Prolia helps to:

Increase bone mass: More bone tissue is preserved over time.
Improve bone density: Bones become thicker and less porous.
Reduce fracture risk: Stronger bones are less likely to break, particularly in the spine, hips, and wrists.

Because the drug remains active in the body for several months, it provides a sustained reduction in bone loss between doses.

Question 4

What are the active ingredients in Prolia?

Accepted Answer

The active ingredient in Prolia is denosumab.

Question 5

What are the side effects of Prolia?

Accepted Answer

Common side effects of Prolia may include:

back pain
extremity pain
musculoskeletal pain

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Prolia?

Accepted Answer

Prolia belongs to the RANKL inhibitor drug class.

Question 7

What is the dosage of Prolia and how do I take it?

Accepted Answer

How Prolia is Given

Prolia is given as an injection under the skin (subcutaneously). It is administered by a healthcare professional in a medical office or clinic. The injection is usually given in the upper arm, the upper thigh, or the stomach area.

Dosing Schedule

This medication is typically given as a single dose every six months. Your healthcare provider will track your treatment schedule to ensure you receive the medication at the correct intervals.

Important Considerations

Supplements: To help maintain healthy bone density and blood calcium levels, your doctor will likely instruct you to take calcium and vitamin D supplements while you are receiving this treatment.
Missed Doses: If you miss a scheduled injection, contact your healthcare provider immediately to reschedule. After receiving the missed dose, your next injection should be scheduled for six months after that date.

Question 8

Is Prolia safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Prolia is not recommended for use during pregnancy because it may cause harm to an unborn baby. Research in animals has shown that exposure to the medication during pregnancy can lead to skeletal abnormalities and issues with the development of the immune system in the fetus.

If you are capable of becoming pregnant, your healthcare provider may perform a pregnancy test before you begin treatment to ensure you are not pregnant. It is important to use effective birth control while receiving Prolia and for at least 5 months after your last dose. If you become pregnant during this time, notify your healthcare provider immediately.

Breastfeeding

It is not known whether Prolia passes into human breast milk. Because of the potential for serious side effects in a nursing infant, healthcare providers typically recommend either stopping breastfeeding or stopping the medication. You should discuss your options with your doctor to determine the best course of action based on your medical needs and the health of your baby.

Question 9

What forms and strengths does Prolia come in?

Accepted Answer

Dosage Forms

Prolia is provided as a liquid solution for subcutaneous injection. It is intended for administration into the fatty tissue under the skin.

The medication is supplied in the following form:

Prefilled Syringe: A delivery system containing the medication as a clear, colorless-to-pale yellow liquid.

Question 10

What is the FDA approval status of Prolia?

Accepted Answer

FDA Approval and Indications

Prolia (denosumab) is approved by the U.S. Food and Drug Administration (FDA) for several uses related to bone health. Its primary indications include:

Treatment of osteoporosis in postmenopausal women at high risk for fracture.
Increasing bone mass in men with osteoporosis at high risk for fracture.
Treatment of glucocorticoid-induced osteoporosis in men and women at high risk for fracture.
Increasing bone mass in men at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer.
Increasing bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer.

Boxed Warning: Severe Hypocalcemia

The FDA has added a Boxed Warning to the prescribing information for Prolia. This warning alerts healthcare providers and patients to an increased risk of severe hypocalcemia (critically low blood calcium levels) in patients with advanced chronic kidney disease, particularly those on dialysis. Severe hypocalcemia can lead to serious health issues, including hospitalization or death. The FDA recommends that healthcare providers screen patients for kidney function before prescribing Prolia and monitor calcium levels closely in those with impaired kidney function.

Biosimilar Availability

In 2024, the FDA approved the first interchangeable biosimilars for Prolia. These medications are biological products that are highly similar to the original drug and have no clinically meaningful differences in terms of safety, purity, and potency.

Question 11

What should I know about Prolia and cost?

Accepted Answer

Insurance and Administration

Prolia is an injectable medication administered by a healthcare professional every six months. Because it is given in a clinical setting, it is frequently covered under medical insurance benefits, such as Medicare Part B, rather than through a standard prescription drug plan. Coverage typically depends on the specific diagnosis and medical necessity as determined by the insurer.

Cost Factors

The total expense for treatment generally includes two components:

The Medication: The price of the Prolia syringe itself.
Administration Fees: The cost charged by the healthcare provider or facility to perform the injection.

Costs may vary significantly between a private doctor's office and a hospital outpatient department. Patients are encouraged to verify coverage with their insurance provider and ask the administering facility for a cost estimate prior to their appointment.

Financial Support

Financial assistance may be available for eligible patients. This can include manufacturer-sponsored co-pay programs for those with commercial insurance or patient assistance programs for individuals who are uninsured or meet specific financial criteria.

Prolia

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Prolia

Hospitals.net Disclosure